$1.73+0.02 (+1.41%)
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally.
Moolec Science SA in the Healthcare sector is trading at $1.73 with a market capitalization of $5M. The stock is currently near its 52-week low of $1.64, remaining 76.6% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 4 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q4 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|
| Total Revenue | β | $2.64Mβ | $1.56Mβ | $1.52Mβ | $2.11M |
| Gross Profit | β | -$674,369β | $14,773β | -$71,643β | $91,743 |
| Operating Income | β | -$2.06Mβ | -$2.10Mβ | -$2.94Mβ | -$2.04M |
| Net Income | β | -$2.43Mβ | -$1.92Mβ | -$2.54Mβ | -$1.40M |
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and in...